Table 1.
Summary of clinical and pathologic information for 207 soft-tissue sarcoma patients
| Characteristic | Value |
|---|---|
| No. of patients | 207 |
| Age [mean±SD (range)] | 56±16 (7–84) |
| Gender (%) † | |
| Female | 102 (50.2) |
| Male | 101 (49.8) |
| Tumor size § | |
| 0–5 cm | 35 (17.4) |
| 5–10 cm | 65 (32.3) |
| 10–15 cm | 43 (21.4) |
| >15 cm | 58 (28.9) |
| Primary site (%) † | |
| Retro-intrabdominal | 60 (29.6) |
| Visceral | |
| Gastrointestinal | 23 (11.3) |
| Genitourinary | 4 (2) |
| Gynecological | 1 (0.5) |
| Thoracic | 12 (5.9) |
| Extremity | 93 (45.8) |
| Trunk | 8 (3.9) |
| Head and Neck | 2 (1) |
| Stage at time of sample procurment ‡ | |
| Primary | 139 (68.8) |
| Local recurrence | 29 (14.4) |
| Distant recurrence | 34 (16.8) |
| Histology | |
| Dedifferentiated liposarcoma | 50 (24.2) |
| Myxoid/round cell liposarcoma | 21 (10.1) |
| Pleomorphic liposarcoma | 24 (11.6) |
| Leiomyosarcoma | 27 (13) |
| Gastrointestinal stromal tumor | |
| Epithelioid | 4 (1.9) |
| Spindle | 11 (5.3) |
| Mixed or unspecified | 7 (3.4) |
| Myxofibrosarcoma | |
| Myxofibrosarcoma | 35 (16.9) |
| Pleomorphic MFH | 3 (1.5) |
| Synovial sarcoma ‖ | |
| Monophasic | 19 (9.2) |
| Biphasic | 4 (1.9) |
| Median follow-up (months) | 35.65 |
| Time to distant recurrence (months) | 15.7 |
| Co-morbidities | 57 (27.5) |
‖
One synovial sarcoma not specified
Data available for §201, †203, and ‡202 patients respectively